Search Results - "Stylianou, Annie"

Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders by Wittenberg, Gayle M., Stylianou, Annie, Zhang, Yun, Sun, Yu, Gupta, Ashutosh, Jagannatha, P. S., Wang, Dai, Hsu, Benjamin, Curran, Mark E., Khan, Shahid, Chen, Guang, Bullmore, Edward T., Drevets, Wayne C.

“…Activation of the innate immune system is commonly associated with depression. Immunomodulatory drugs may have efficacy for depressive symptoms that are…”
Get full text

Supporting the next generation of non-communicable disease research leaders in Africa – experience of the GSK Africa NCD Open Lab by Addo, Juliet, Strange, Mike, Kendall, Lindsay, Stylianou, Annie, Gatsi, Sally, Guta, Phyllis, Scott, Rhona, Ako, Agbor

“…Background Despite a large and increasing non-communicable diseases (NCD) burden in Africa, research to inform NCD risk factors, management and outcomes in…”
Get full text

Replicable and Coupled Changes in Innate and Adaptive Immune Gene Expression in Two Case-Control Studies of Blood Microarrays in Major Depressive Disorder by Leday, Gwenaël G.R., Vértes, Petra E., Richardson, Sylvia, Greene, Jonathan R., Regan, Tim, Khan, Shahid, Henderson, Robbie, Freeman, Tom C., Pariante, Carmine M., Harrison, Neil A., Bullmore, Edward, Bullmore, Edward, Vertes, Petra, Cardinal, Rudolf, Richardson, Sylvia, Leday, Gwenael, Freeman, Tom, Regan, Tim, Hume, David, Wu, Zhaozong, Pariante, Carmine, Cattaneo, Annamaria, Zunszain, Patricia, Borsini, Alessandra, Stewart, Robert, Chandran, David, Carvalho, Livia, Bell, Joshua, Souza-Teodoro, Luis, Perry, Hugh, Harrison, Neil, Drevets, Wayne, Wittenberg, Gayle, Jones, Declan, Khan, Shahid, Stylianou, Annie, Henderson, Robbie, Perry, V. Hugh, Drevets, Wayne C., Wittenberg, Gayle M., Bullmore, Edward T.

“…Peripheral inflammation is often associated with major depressive disorder (MDD), and immunological biomarkers of depression remain a focus of investigation…”
Get full text

Pharmacokinetics and safety of inhaled oxytocin compared with intramuscular oxytocin in women in the third stage of labour: A randomized open‐label study by Gajewska‐Knapik, Katarzyna, Kumar, Subramanya, Sutton‐Cole, Amy, Palmer, Kirsten R., Cahn, Anthony, Gibson, Rachel A., Kirkpatrick, Carl, Parry, Simon, Schneider, Ian, Siederer, Sarah, Stylianou, Annie, Hacquoil, Kimberley, Powell, Marcy, Ellis, Melissa, McIntosh, Michelle P., Lambert, Pete

“…Aims To compare pharmacokinetics (PK) and safety of heat‐stable inhaled (IH) oxytocin with intramuscular (IM) oxytocin in women in third stage of labour (TSL),…”
Get full text

Repeated exposure to systemic inflammation and risk of new depressive symptoms among older adults by Bell, J A, Kivimäki, M, Bullmore, E T, Steptoe, A, Carvalho, L A

“…Evidence on systemic inflammation as a risk factor for future depression is inconsistent, possibly due to a lack of regard for persistency of exposure. We…”
Get full text

120. A study to investigate calcium mechanisms in women at high risk of pre-eclampsia through analysis of putative protein markers. A sub-study of the calcium and pre-eclampsia (CAP) study (a WHO collaboration) by Stylianou, Annie, Sun, Min, Gibson, Rachel, Roberts, James, Ciganda, Alvaro, Mose, Simpiwe, Singata-Madliki, Mandisa, Fawcus, Sue

“…The mechanisms by which calcium reduces the severity of preeclampsia are currently not established. Blood samples were studied from participants in CAP, a…”
Get full text

Quantitative decision making for investment in global health intervention trials: Case study of the NEWBORN study on emollient therapy in preterm infants in Kenya by Stylianou, Annie, Blanks, Keona J H, Gibson, Rachel A, Kendall, Lindsay K, English, Mike, Williams, Sarah, Mehta, Roshni, Clarke, Andrew, Kanyuuru, Lynn, Aluvaala, Jalemba, Darmstadt, Gary L

“…BackgroundPartners from an NGO, academia, industry and government applied a tool originating in the private sector – Quantitative Decision Making (QDM) – to…”
Get full text

The relative bioavailability of 2 prototype fixed-dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjects by Nwe, Htar H., Bullman, Jonathan N., Joshi, Shashidhar M., Stylianou, Annie, Kapsi, Shiva G.

“…A fixed‐dose combination (FDC) may improve patient compliance and clinical outcomes in the management of cardiovascular risk in hypertensive and dyslipidemic…”
Get full text